Loading menu...
Prostate cancer is the second leading cause of cancer deaths among US men  Over 200,000 new patients are diagnosed with prostate cancer every year in the US alone  About 35,000 of these men have advanced metatstatic prostate tumor for whom there is no cure 

Scientific Advisory Board

 

Colby's scientific advisory board (SAB) includes academic and industry thought leaders in oncology and oxidative stress. The members of SAB were insrumental to Colby's drug candidate and drug discovery platform development and are actively engaged in shaping both pre-clinical and clinical drug development strategies.